Chengda Pharmaceuticals Co (SZSE:301201) Construction In Progress : ¥66.2 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Chengda Pharmaceuticals Co Construction In Progress?

Chengda Pharmaceuticals Co's quarterly construction in progress declined from Sep. 2024 (¥253.2 Mil) to Dec. 2024 (¥101.5 Mil) and declined from Dec. 2024 (¥101.5 Mil) to Mar. 2025 (¥66.2 Mil).

Chengda Pharmaceuticals Co's annual construction in progress increased from Dec. 2022 (¥153.5 Mil) to Dec. 2023 (¥179.2 Mil) but then declined from Dec. 2023 (¥179.2 Mil) to Dec. 2024 (¥101.5 Mil).

Chengda Pharmaceuticals Co Construction In Progress Historical Data

The historical data trend for Chengda Pharmaceuticals Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengda Pharmaceuticals Co Construction In Progress Chart

Chengda Pharmaceuticals Co Annual Data

Trend

Dec09

Dec10

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

66.63

70.70

153.53

179.17

101.46

Chengda Pharmaceuticals Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															167.15	199.29	253.21	101.46	66.16

Chengda Pharmaceuticals Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Chengda Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengda Pharmaceuticals Co Ltd (SZSE:301201) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

36 Huanghe Road, Huimin Street, Jiashan County, Zhejiang Province, Jiaxing, CHN, 314100

Website

http://www.chengdapharm.com

Chengda Pharmaceuticals Co Ltd is engaged in the research and development, production and sales of L-carnitine series products. The company mainly produces raw materials, food additives, feed additives, antibiotics, anti-cancer, anti-virus and other series of pharmaceutical intermediates. The products are sold to more than 30 countries and regions.

Chengda Pharmaceuticals Co Headlines

No Headlines